𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5.28 Combining Fludarabine and Rituximab With Escalating Doses of Lenalidomide in Untreated Chronic Lymphocytic Leukemia: The REVLIRIT CLL5 AGMT Phase 1/2 Study—Results from Clinical and Exploratory Analyses of Induction

✍ Scribed by A. Egle; M. Steurer; F. Gassner; R. Geisberger; T. Melchardt; L. Weiss; M. Fridrik; J. Thaler; A. Lang; R. Greil

Book ID
119218972
Publisher
Elsevier
Year
2011
Tongue
English
Weight
89 KB
Volume
11
Category
Article
ISSN
2152-2650

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5.44 Consolidation Therapy with Subcutan
5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)
✍ Alain Delmer; Olivier Tournilhac; Stéphane Leprêtre; Bruno Cazin; Pierre Feugier 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 113 KB